Clinical Trials
7 trialsNCT06760819 2026-05-07
panSOHO
Bayer
Phase 2 Recruiting
NCT06638931 2026-04-15
ANTARES
Instituto do Cancer do Estado de São Paulo
Phase 2 Recruiting
NCT07146646 2026-02-19
Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer
Case Comprehensive Cancer Center
Phase 2 Recruiting
NCT07025174 2025-06-17
SAIB
First Affiliated Hospital of Zhejiang University
Phase 2 Recruiting
NCT06852287 2025-02-28
GOLD-HAIC
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT04183712 2024-10-16
Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
Shanghai Jiao Tong University School of Medicine
Phase 2 Recruiting
NCT05757336 2023-03-07
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer
Fudan University
Phase 2 Recruiting